search
Search
International Finance Facility for Immunisation issues first Sukuk, raising US$ 500 million
Funding to support immunisation of children in the poorest countries through Gavi Dubai, UAE, 27 November 2014 – The International Finance Facility for Immunisation Company (IFFIm) today issued its inaugural Sukuk, raising US$ 500 million for…
Japanese investors welcome the launch of IFFIm’s debut 'vaccine bonds'
Japanese investors welcomed the launch of the debut offering in the Japanese market of the International Finance Facility for Immunisation Company Tokyo, 4 March 2008 - Japanese investors enthusiastically welcomed the launch of the debut offering…
IFFIm’s inaugural sterling offering raises GBP 266 million for vaccine programmes
Retail and institutional investors welcome the unique opportunity to make an investment that protects millions of lives against preventable diseases. London, 15 May 2009 - The International Finance Facility for Immunisation Company (IFFIm)…
Canada pledges C$ 125 million to IFFIm
Canada expands its commitment to childhood immunisation as 11th donor to IFFIm C$ 125 million grant brings IFFIm’s donor support to nearly US$ 10 billion committed through 2037 Seth Berkley, Gavi CEO: “Canada’s pledge will support Gavi’s…
Statement by Julian Lob-Levyt, GAVI Alliance Executive Secretary at the conference on Innovative Financing for Development
Conference on Innovative Financing for Development Geneva, 2 March 2006 - GAVI congratulates France and the UK for their years of work invested in the search for creative new ways to pay for the measures that will be needed to meet the Millennium…
IFFIm Vaccine Bond issuance named 2019 "Deal of the Year" by mtn-i
London, 6 February 2020 - IFFIm, Skandinaviska Enskilda Banken (SEB) and the Toronto-Dominion Bank have been awarded SRI “Deal of the Year” by news, data and analytics publisher mtn-i for a July 2019 Vaccine Bond issuance that raised funding to…
South Africa joins IFFIm
The Republic of South Africa joins the International Finance Facility for Immunisation as its seventh government donor London, 16 March 2007 - The Republic of South Africa today joined the International Finance Facility for Immunisation (IFFIm),…
IFFIm helps COVAX bring fair, global access to COVID-19 vaccines
With vaccine bonds, donors and private investors are tackling the toughest global health crisis in a century In the spring of 2020, as the novel coronavirus began to envelop the world, it was clear that a vaccine, available everywhere, would be…
IFFIm raises more than US$ 2 billion to support life-saving immunisation programmes in poorest countries
The International Finance Facility for Immunisation satisfies strong demand for ethical investments and helps ensure children are vaccinated Press Releases Geneva, 19 May 2009 - The International Finance Facility for Immunisation (IFFIm) has…
The Lay of the land
The Lay of the Land: Q&A with IFFIm Board Chair Kenneth Lay Ken Lay was just 24 and not yet out of law school when he went to work at the SEC and started his career in finance. That job, and the mentors he met, set Ken on a career that brought…
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.